Clinical Trial Update: Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating progesterone supplementation in HIV-positive pregnant women on antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PROGESTERONE (Progesterone)

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: HIV-1 Infection | Phase 2 | Status: UNKNOWN